Your browser doesn't support javascript.
loading
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
Goldfarb, David S; MacDonald, Patricia A; Gunawardhana, Lhanoo; Chefo, Solomon; McLean, Lachy.
Affiliation
  • Goldfarb DS; Nephrology Section, New York Harbor VA Medical Center, and Division of Nephrology, New York University Langone Medical Center, New York, New York;, †Global Medical Affairs, Takeda Pharmaceuticals International, Deerfield, Illinois;, ‡Clinical Science, and §Statistics, Takeda Global Research & Development Center, Inc., Deerfield, Illinois, ‖Experimental Medicine, Takeda California, San Diego, California.
Clin J Am Soc Nephrol ; 8(11): 1960-7, 2013 Nov.
Article in En | MEDLINE | ID: mdl-23929928

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Uric Acid / Xanthine Oxidase / Calcium Oxalate / Urinary Calculi / Allopurinol / Enzyme Inhibitors Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2013 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Uric Acid / Xanthine Oxidase / Calcium Oxalate / Urinary Calculi / Allopurinol / Enzyme Inhibitors Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2013 Document type: Article Country of publication: United States